Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $50,000,021 |
Sells | 202 | $136,298,501 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 202,238 | 25.3 | 5,116,621 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | D |
14 Dec 2022 16:55 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND II, L.P. | 10% | 12 Dec 2022 | Purchase | 934,581 | 10.7 | 10,000,017 | D |
14 Dec 2022 16:56 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 12 Dec 2022 | Purchase | 934,581 | 10.7 | 10,000,017 | I |
11 Jan 2024 16:31 | DYN | Dyne Therapeutics Inc | KERSTEN DIRK | Director , 10% | 09 Jan 2024 | Purchase | 1,428,571 | 17.5 | 24,999,992 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)